Key Metrics
5.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.87 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Oncology
SJR
- Q3 Oncology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.89
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Assay
- Overall survival
- Lung cancer
- Western blot
- Lymph node
- Computed tomography
- Progression-free survival
- Multivariate analysis
- Albumin
- Breast cancer
- Hepatocellular carcinoma
- Nasopharyngeal carcinoma
- Cell cycle
- Irradiation
- Toxicity
- Lung
- Surgery
- Osteosarcoma
- Hysterectomy
Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2410 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 16 |
| Article Processing Charges | USD 2410 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Cancer Management and Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Effects of Metformin on JNK Signaling Pathway and PD-L1 Expression in Triple Negative Breast Cancer.
- 1 Apr 24
- Cancer management and research
-
Full paper
Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials.
- 1 Apr 24
- Cancer management and research
-
Full paper
OCT4 Accelerates Tumorigenesis Through Activating JAK/STAT Signaling in Ovarian Cancer Side Population Cells [Retraction].
- 1 Apr 24
- Cancer management and research
-
Full paper
Comparative Analysis of Oncologic Outcomes in Patients with Squamous Cell Carcinoma of the Uterine Cervix with High-Risk Features for Para-Aortic Recurrence: Prophylactic Extended-Field versus Pelvic Chemoradiotherapy.
- 1 Apr 24
- Cancer management and research
-
Full paper
Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update.
- 1 Apr 24
- Cancer management and research
-
Full paper
Efficacy and Safety of Maintenance Therapy Using Cetuximab in Patients with Metastatic Colorectal Cancer: Retrospective Study.
- 1 Mar 24
- Cancer management and research
Scite analysis
Powered by scite_
4.7k articles received 49.6k citations see all
- 2,160 Supporting
- 46,568 Mentioning
- 305 Contrasting
Editorial notices
- 80 Retractions
- 0 Withdrawals
- 0 Corrections
- 67 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
28%
4 to 6 months
61%
7 to 9 months
9%
Above 9 months
2%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Cancer Management and Research been actively publishing?
Cancer Management and Research has been in operation since 2009 till date.
What is the publishing frequency of Cancer Management and Research ?
Cancer Management and Research published with a Continuous publication frequency.
How many articles did Cancer Management and Research publish last years ?
In 2023, Cancer Management and Research published 148 articles.
What is the eISSN & pISSN for Cancer Management and Research ?
For Cancer Management and Research,eISSN is 1179-1322 and pISSN is1179-1322.
What is Citescore for Cancer Management and Research ?
Citescore for Cancer Management and Research is 5.4.
What is SNIP score for Cancer Management and Research ?
SNIP score for Cancer Management and Research is 0.89.
What is the SJR for Cancer Management and Research ?
SJR for Cancer Management and Research is Q3.
Who is the publisher of Cancer Management and Research ?
DOVE MEDICAL PRESS LTD is the publisher of Cancer Management and Research.